CoChat

Emerging clinical and experimental evidence for the role of lipocalin‐2 in metabolic syndrome

Jang, Yangsoo, Lee, Jong Ho, Wang, Yu, Sweeney, Gary · 2012 · Clinical and Experimental Pharmacology and Physiology
Cited by 64

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Summary: 1. The inflammatory state, which is associated with the current pandemic of obesity, has been established as an important contributing pathogenic factor to the increased prevalence of the so‐called metabolic syndrome. Many studies have focused on the contribution of various adipokines to this phenomenon, and in the present study, we provide an update on the emerging evidence that the pro‐inflammatory factor, lipocalin‐2, might influence various aspects of metabolic syndrome. 2. Previous reports indicate a positive correlation of serum lipocalin‐2 with fasting glucose, the homeostasis model assessment of insulin resistance index, and the inflammatory marker high‐sensitivity C‐reactive protein, even after adjustment for body mass index, suggesting that it is an independent risk factor for insulin resistance, diabetes, and inflammation. Direct analysis of lipocalin‐2 action now also shows effects on peripheral metabolism and on cardiovascular function. 3. A better understanding of how lipocalin‐2 is regulated locally and systemically is crucial for adding to our understanding of the pathogenesis of metabolic syndrome, and to uncover potential new avenues for therapeutic approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1681.2011.05557.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 64

Metadata

Authors
Jang, Y., Lee, J. H., Wang, Y., & Sweeney, G.
Venue
Clinical and Experimental Pharmacology and Physiology
Publisher
Wiley
Published
2012-01-30
Volume
39
Issue
2
Pages
194-199
ISSN
  • 0305-1870 (ISSN-L)
  • 1440-1681
OpenAlex
W2159493243
Cited by
64
References
7
FWCI
3.24
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Emerging clinical and experimental evidence for the role of lipocalin‐2 in metabolic syndrome. https://app.cochat.ai/papers/10.1111/j.1440-1681.2011.05557.x
The paper
Jang, Y., Lee, J. H., Wang, Y., & Sweeney, G. (2012). Emerging clinical and experimental evidence for the role of lipocalin‐2 in metabolic syndrome. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/j.1440-1681.2011.05557.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.